Literature DB >> 19695863

The current state of introduction of HPV vaccination into national immunisation schedules in Europe: results of the VENICE 2008 survey.

D Lévy-Bruhl1, V Bousquet, L A King, D O'Flanagan, S Bacci, P L Lopalco, S Salmaso.   

Abstract

Three surveys have been undertaken in European Union (EU) member states since January 2007, within the European Commission funded Vaccine European New Integrated Collaboration Effort (VENICE) project, to monitor the decision status regarding the introduction of human papillomavirus (HPV) vaccination into national immunisation schedules. A web-based questionnaire was developed and completed online by the 28 countries participating in VENICE. According to the last update (31st December 2008), 15 countries have decided to introduce HPV vaccination into their national immunisation schedule, while another six have started the decision-making process with a recommendation favouring introduction. Varying target populations have been selected by the countries which have introduced vaccination. The number of countries which have made a decision or recommendation has increased from 12 to 21 between October 2007 and December 2008. This survey demonstrates the rapidly evolving nature of HPV vaccine introduction in Europe. A further update should be available in the second half of 2009.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19695863     DOI: 10.1016/j.ejca.2009.07.023

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  11 in total

Review 1.  Vaccines to prevent infections by oncoviruses.

Authors:  John T Schiller; Douglas R Lowy
Journal:  Annu Rev Microbiol       Date:  2010       Impact factor: 15.500

Review 2.  Monitoring of human papillomavirus vaccination.

Authors:  J Dillner; M Arbyn; E Unger; L Dillner
Journal:  Clin Exp Immunol       Date:  2010-11-09       Impact factor: 4.330

3.  HPV genotypes in the oral cavity/oropharynx of children and adolescents: cross-sectional survey in Poland.

Authors:  Julia Durzyńska; Joanna Pacholska-Bogalska; Maria Kaczmarek; Tomasz Hanć; Magdalena Durda; Magdalena Skrzypczak; Anna Goździcka-Józefiak
Journal:  Eur J Pediatr       Date:  2010-11-24       Impact factor: 3.183

4.  Global challenges of implementing human papillomavirus vaccines.

Authors:  Janice E Graham; Amrita Mishra
Journal:  Int J Equity Health       Date:  2011-06-30

5.  Primary screening for human papillomavirus compared with cytology screening for cervical cancer in European settings: cost effectiveness analysis based on a Dutch microsimulation model.

Authors:  Inge M C M de Kok; Joost van Rosmalen; Joakim Dillner; Marc Arbyn; Peter Sasieni; Thomas Iftner; Marjolein van Ballegooijen
Journal:  BMJ       Date:  2012-03-05

6.  Targeting human papillomavirus to reduce the burden of cervical, vulvar and vaginal cancer and pre-invasive neoplasia: establishing the baseline for surveillance.

Authors:  Mari Nygård; Bo Terning Hansen; Joakim Dillner; Christian Munk; Kristján Oddsson; Laufey Tryggvadottir; Maria Hortlund; Kai-Li Liaw; Erik J Dasbach; Susanne Krüger Kjær
Journal:  PLoS One       Date:  2014-02-05       Impact factor: 3.240

7.  French women's knowledge of and attitudes towards cervical cancer prevention and the acceptability of HPV vaccination among those with 14 - 18 year old daughters: a quantitative-qualitative study.

Authors:  Julie Haesebaert; Delphine Lutringer-Magnin; Julie Kalecinski; Giovanna Barone; Anne-Carole Jacquard; Véronique Régnier; Yann Leocmach; Philippe Vanhems; Franck Chauvin; Christine Lasset
Journal:  BMC Public Health       Date:  2012-11-27       Impact factor: 3.295

8.  Vaccinating women previously exposed to human papillomavirus: a cost-effectiveness analysis of the bivalent vaccine.

Authors:  Hugo C Turner; Iacopo Baussano; Geoff P Garnett
Journal:  PLoS One       Date:  2013-09-26       Impact factor: 3.240

9.  Attitude, Acceptability and Knowledge of HPV Vaccination among Local University Students in Hong Kong.

Authors:  Vico Chung Lim Chiang; Ho Ting Wong; Pui Chun Au Yeung; Yuk Ki Choi; Michelle Sum Yue Fok; Oi In Mak; Hing Yu Wong; Kim Ho Wong; Shui Yan Wong; Yee Shan Wong; Eugene Ying Yeung Wong
Journal:  Int J Environ Res Public Health       Date:  2016-05-11       Impact factor: 3.390

Review 10.  A one health approach to vaccines against Toxoplasma gondii.

Authors:  Elisabeth A Innes; Clare Hamilton; Joao L Garcia; Andreas Chryssafidis; David Smith
Journal:  Food Waterborne Parasitol       Date:  2019-04-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.